Very happy to share today this excellente news for the development of #Biomunex.
For more than 5 years, with one of our key Expert-in-Residence, Stéphane MILOT, with Loïc MOULARD also for a few months, at the helm of the outsourced Financial Department, as well as our support around different strategic and operational perspectives, #LallianSe is pleased to contribute to the success of Biomunex.
Congratulations to the entire team for starting this clinical study ! 👏
Since its creation in 1947, by supporting research, the Fondation pour la Recherche Médicale plays a crucial role in the development of research projects and support for researchers.
The #valorization of this work represents a strategic and significant approach while resulting from a plural and complex process. This is why, with our know-how and our tailor-made courses, #LallianSe has been supporting the #FRM for several years to initiate, explore and develop its inspiring and original approach, making it a unique player in the valorization and maturation of biomedical research projects.
More than a #collaboration, this relationship is based on common values and a shared ambition. We are proud to count the #FRM among our #partners.
This is the key word of this month of November where we had the pleasure of welcomingJean-François BREPSON during the 4th 𝐄𝐦𝐛𝐮̂𝐜𝐡𝐞𝐬 𝐝𝐞 𝐥’𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 : series of testimonies followed by an open and taboo-free exchange.
#CEOPathoQuest, a key player in the French bioproduction sector of innovative medicines but also historical relationship LallianSe since its creation 8 years ago, the developments of PathoQuest under the impetus and leadership of Jean-François offer a fine example of agile and efficient growth… even if it has not been an easy journey.
Cultivating #resilience, learning to turn failures into opportunities and using this shared experience to adjust your approach to the future is essential.
Then share a concrete and inspiring example based on values and our common ethics in a new episode of Do You Speak LallianSe ?
For more than 70 years, the Fondation pour la Recherche Médicale has been the essential private player in financing biomedical research in France. Since 2013, through the management of the Béatrice Denys Foundation under the aegis of the #FRM, the relationship with Julie has been created. And, since 2019 #LallianSe has been supporting the #FRM to initiate, explore and develop its inspiring and original approach to become a relevant player in the promotion and maturation of research projects.
Beyond the #sparringpartner and #operatingpartner approach, Julie & Emmanuelle have built a relationship of trust and quality by concretizing strategic issues, supporting operational implementation, by carrying out targeted interactions with stakeholders. keys while supporting internal teams on a daily basis.
Finally, sharing expertise and defining common objectives are the keys to health innovation.
This is why we actively participated in the CHU Healthtech Connexion Day, organized by France Biotech in Marseille. During a workshop, Julie shared the fruits of our numerous #initiatives resulting from our hospital immersion, thus answering essential questions: how to define innovation – medical and paramedical – in hospitals? What are the conditions for the emergence of innovation in hospitals?
To innovate and develop effective health solutions, we must understand and absorb the needs of the market, staff, users and especially patients. We have been present in the field, for the last 8 years, to outline trajectories through our innovation competitions (#ChallengeInnovation/ #ParInnovChallenge), more recently, the creation of #ASIIA or our flagship initiatives like BrainTale.
Our commitment doesn’t stop there! And speaking of BrainTale, Julie inaugurated GROUPE MACSF brand new podcast project by answering a more general question: how to improve the health of tomorrow?
Julie was able to present a future in which, thanks to a better knowledge of the brain, BrainTale, will allow us to anticipate, prevent and adjust our care pathways and our preventive vision to improve our brain health. 🎧 To listen to it, go here.
#DECEMBER
#PARTNERSHIP
At #LallianSe, we believe in the power of #synergies, #network and shared #values.
A recent Doctor of Pharmacy graduate, Eilone has led important work on the question of how #CDMOs drive innovation within the biologics industry. With her in-depth understanding of the CDMO market and landscape, as well as her experience in #capitaldev, Eilone joined our #Expert #network a few months ago as a junior project manager. At (only) 27 years old, his added value and vision brought dynamic energy and strengthened our commitment to the younger generation. Meet Eilone in our latest 𝐃𝐨𝐘𝐨𝐮𝐒𝐩𝐞𝐚𝐤𝐋𝐚𝐥𝐥𝐢𝐚𝐧𝐒𝐞 ?
Being an integrator means helping to open up perspectives to build an environment favorable to the success of health innovations – and this requires the integration of the international vision…
This year again LallianSe will be present in San Francisco for #JPMorgan week and will partner with #BusinessFrance for #FrenchHealthcareAfterwork next Monday January 8.
For the 3rd consecutive year we are a partner of BioFIT Event, a European event dedicated to technology transfer, collaborations between industrialists and academics and early-stage innovations.
#BioFIT is also a European marketplace for seed #investment and venture capital. As a #Health Integrator, #LallianSe supports the actions around this event: an #opportunity to explore future #collaborations with the ecosystem.
And finally how to evaluate the potential of your innovation and how to create a solid value proposition of your startup?
Remember, we started the summer of 2023 by inaugurating the 1st edition of the “Startup Alumni Breakfasts” of the Institut Pasteur. Invited by Alexandre Batch during the 2nd session of the “Startup Breakfast” Julie had the opportunity to answer these questions in an interactive format.
Crucial steps for the success of #startups, since 2015 LallianSe has made it its mission: to build the environment favorable to the economic success of health innovations by articulating investment theses, through tailor-made courses and an approach agile.
We were happy to contribute to these questions. We are also preparing a surprise for you with the Institut Pasteur… stay tuned!
Finally… to everyone – clients, experts and entrepreneurs in residence, coworkers, partners, entrepreneurs, investors, hospital staff and all those who follow our adventures:
The year #2023 is ending, it’s time to wish you all a very happy holiday. But also to say M E R C I! #Thank you for these #synergies, these exchanges, and these projects, which are always more inspiring, attractive and motivating. Thanks to you, a virtuous circle is being built, and this is the greatest reward for us.
How to assess the potential of your #innovation and how to create a solid value proposition for your #startup?
Remember, we started the summer of 2023 by inaugurating the 1st edition of the “Startup Alumni Breakfasts” at the Institut Pasteur. Yesterday, invited by Alexandre Batch, PhD – MBA during the 2nd session of the “Startup Breakfast” Julie had the opportunity to answer these questions in an #interactive format.
Crucial steps for the success of #startups, since 2015 #LallianSe has made it its mission: to build the environment favorable to the economic success of health innovations by articulating investment theses, through tailor-made #pathways and an #agile approach.
July 6th 2023
We were asked by Alexandre Batch, PhD – MBA to co-organize and inaugurate the 1st edition of the “Startup Alumni Breakfasts” of the Institut Pasteur on the theme How can governance become a tool for investor relations ?
Governance is at the heart of strategy and particularly in relations with investors. This informal breakfast thus proposed to explore and share with concrete cases the strategic interest of governance in the creation of company value .
Thanks to Alexandre Batch, PhD – MBA & Marion Le Foll for giving us carte blanche to invite Connie Coulomb, vice-president of the specialized investment bank BioPharma Capital, based in the US. In a format of exchange of experiences, the dialogue also made it possible to discuss the similarities and differences between the EU and the United States.
For the 3rd consecutive year we are #partner of BioFIT Event, a European event dedicated to technology transfer, collaborations between industrialists and academics and early-stage innovations.
#BioFIT is also a European marketplace for seed #investment and venture capital. In Marseille on December 12 & 13 and online on December 15, 2023.
For the 2nd year we are #partner of #MedFIT: European event dedicated to #medtech and #health in general. In Strasbourg on October 10 & 11 and online on October 17, 2023..
BioFIT Event is the leading #event in Europe for technology transfer, academia-industry collaborations and early-stage innovations in the field of Life Sciences. It is also the European marketplace for seed capital and venture capital investment in Life Sciences.
It is in particular with her #BrainTaleCEO‘s cap that Julie Rachline was present. Indeed, LallianSe builds, develops and manages the equity story of BrainTale, our flagship initiative since 2016 :
– Cofounding of the company with Vincent Perlbarg, Didier Cassereau, Louis Puybasset, Damien Galanaud & Velly Lionel – Integration and reinforcement of the team, – Accommodation in hospital coworking, – Management of experts and entrepreneurs in residence, – Fundraising…
2021 Partnership BioFIT x MedFIT
You had the opportunity to meet us during the 10th edition of #BioFIT2021 and the 5th edition of #MedFIT2021 in digital format from December 7 to 9, 2021 where LallianSe was a partner.
BioFIT Event is the leading event in Europe for technology transfer, academia-industry collaborations and early-stage innovations in the field of Life Sciences. BioFIT is also the European marketplace for seed and venture capital investment in Life Sciences. www.biofit-event.com
MedFIT Event is the first European convention dedicated to partnership innovation and the marketplace for early-stage innovations in the field of medical technologies, diagnostics and digital health. www.medfit-event.com
Recently graduated Doctor of #Pharmacy, Eilone Abensour has led important work on the question of how #CDMOs drive innovation within the biologics industry.
With her in-depth understanding of the CDMO market and landscape, as well as her experience in #capitaldev, Eilone joined our #Expert #network a few months ago as a junior project manager. At (only) 27 years old, his added value and vision brought dynamic energy and strengthened our commitment to the younger generation.
At #LallianSe, we believe in the power of #synergies, #network and shared #values.
No need to present the annual J.P Morgan conference and its decisive impact as the first event of the year. Since 2020, LallianSe has been a partner of Business France to support the deployment of the French ecosystem in the United States and support its clients in investor, banker and pharmaceutical industrial relations.
As such, we are pleased to invite you to the French Healthcare Afterwork which will take place onMonday January 8, 2024, from 5 pm to 7 pm at the French Corner, specifically organized for the French delegation.
The entire LallianSe team sends you its best wishes!
We wish you a 2024 full of meetings, great projects and many successes. Hoping that our renewed commitment alongside health entrepreneurs and innovators will open up avenues for exchange and collaboration. For 2024 – and beyond, let’s break down barriers and build tomorrow’s health together.
For more than 70 years, the Fondation pour la Recherche Médicale has been the essential private player in financing biomedical research in France.
Since 2013, through the management of the Béatrice Denys Foundation under the aegis of the #FRM, the relationship with Julie has been created. And, since 2019 #LallianSe has been supporting the #FRM to initiate, explore and develop its inspiring and original approach to become a relevant player in the promotion and maturation of research projects.
Beyond the #sparringpartner and #operatingpartner approach, Julie and Emmanuelle have built a relationship of trust and quality by concretizing strategic issues, supporting operational implementation, by carrying out targeted interactions with stakeholders. keys while supporting internal teams on a daily basis.
A concrete and inspiring example based on values and our common ethics. Thank you to Valerie Lemarchandel & Florence Guibal and all the FRM teams for your trust!
For the past year, we have been collaborating with the Institut Imagine through its Bioentrepreneurs Launchpad program, focusing on training #entrepreneurs and accelerating #startup projects.
We are thrilled to highlight a new synergy today with Anna, a communication specialist in France and internationally, who has contributed her #expertise to support project teams.
In our #DYSL, her mastery of the subject had already convinced us in crafting our narrative and also in the communication strategy of our flagship initiative, BrainTale.
In the deployment of its hospital immersion initiatives and LallianSeEducation, the University Diploma of Sorbonne, DU GBM, whose management is ensured by Julie Rachline and whose organization is partly operated by LallianSe, we are proud to announce a new synergy made by LallianSe: a cross partnership between the DU GBM of Sorbonne Université, and the Bioentrepreneurs Launchpad program launched by the Imagine Institute – X-HEC Entrepreneurs & Université Paris Cité, Université Paris-Saclay & ESCP Business School.With very complementary approaches, one for acculturation to valorization and the other for the creation of startups, we decided to combine these training courses in order to offer 2 tailor-made courses. Contact us at du.gbm@lallianse.com now!
Launched by the Institut Imagine – X-HEC Entrepreneurs & Université Paris Cité, this is a program for training #entrepreneurs and accelerating #startup#healthtech projects, with a strong impact for patients s addressed to scientists, pharmacists, engineers or even business and legal.
Three LallianSe #Experts ensured this collaboration this year: Pascale Maisonneuve around strategic #regulatory aspects, followed by a 2nd one with Emmanuelle Deponge with an #investor focus and finally the last one with Chantal BELORGEY (Haute Autorité de Santé) about the market access. Three essential axes that make up the investment thesis!
Sharing our experiences by supporting the training of the professionals of tomorrow: this is the approach that we favor, in addition to our other activities, to build the environment favorable to the #success of #innovations.
